- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
IDGLOBAL (Pink Sheets:IDGJ) is providing its January Corporate update and full year 2008 outlook.
IDGLOBAL's business model of delivering and showcasing its Nano-Molecular Markers™ for Anti-Counterfeiting and IDFORENSIX™ for Anti-Theft/loss prevention products will continue through an aggressive tradeshow and conference schedule throughout the 2008 fiscal year. Revenues and the roster of clients for its Nano-Molecular Markers™ has grown significantly in fiscal year 2007 and IDGLOBAL is engaged in multiple pilot projects, proposals and early stage discussions with a number of Fortune 100 companies. IDGLOBAL has been receiving client inquiries and requests for demonstrations and pilot project testing for its Nano-Molecular Anti-Counterfeiting Solutions at a significant pace as a direct result of its strategy associated with demonstrating its products at high-profile events and tradeshows. IDGLOBAL shall release information regarding any material developments as they become available.
Beginning IDGLOBAL's second full year of operation, IDGLOBAL anticipates a break-even financial condition for 2008. This can be augmented to a polarity given multiple successful client acquisitions; however, IDGLOBAL Management prefers a conservative opinion in providing the markets with forward-looking financial information.
January 2008 Corporate Update
In January 2008, IDGLOBAL will be engaging in multiple client meetings, discussions and advancing opportunities associated with recent meetings with high-level Barristers/Lawyers and some of Silicon Valley's largest organizations that include Apparel, Garment and Technical Corporations as well as specific discussions in the Pharmaceutical verticals.
Also in January, IDGLOBAL will begin working directly with its partner, ATL Pharma Security Label Systems™ (www.atlco.com), a division of Ad Tape & Label Co, in directly marketing IDGLOBAL'S Nano-Molecular Markers™ to ATL's list of Pharmaceutical clients which include some of the largest Pharmaceutical companies in that vertical. IDGLOBAL secured an unprecedented ten (10)-year contract to supply its Nano-Molecular Marking™, anti-counterfeiting technology to ATL Pharma Security Label Systems™ as announced back on July 24, 2007 and December 4, 2007.
ATL is one of the world's leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major Pharmaceutical corporations. In the past 7 years ATL has produced more than 120 million pharmaceutical labels (including 19 page booklets), in over 80 languages, for over 1,700 clinical trials. In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in "private brand" disposable medical device manufacturing. See attached link Pharmaceutical Counterfeiting for more information: http://www.atlco.com/medical/PharmaAntiCounterfeiting.html
Chief Technical Officer Hired (CTO)
IDGLOBAL continues to grow its base of qualified and technical staffing with the hiring of a Chief Technical Officer (CTO) to overlook and guide the Research and Development and technical infrastructure of the company. IDGLOBAL will provide specifics on this individual very shortly.
Research and Development
IDGLOBAL has expanded its use of its Nano-Molecular Markers™ to include Military and Munitions applications. Prior tests successfully concluded that its Nano-Molecular Markers survived detonation of the munitions and sees multiple applications going forward. IDGLOBAL sees this application as a potentially significant weapon in equipping Authorities in combating Terrorist and criminal activities.
IDGLOBAL provides a range of leading technologies specifically designed to provide private enterprise and governments 100% solutions to their Counterfeiting infections and Loss Prevention/Anti-Theft security programs. IDGLOBAL’s Nano-Molecular Markers/Tags™ are specifically designed for global anti-counterfeiting applications and its IDFORENSIX™ products provide Loss Prevention/Anti-Theft solutions for the annual $800 billion Anti-Counterfeiting and Loss Prevention markets. IDGLOBAL is a forward-looking company with a robust R&D program and product development and integration program for the purpose of providing next-generation Nano-based and leading-edge Anti-Counterfeiting products and Security solutions.
Nano-Molecular, Nano-Molecular Markers, Nano-Molecular Tags and IDFORENSIX are registered trademarks of IDGLOBAL Corp., All Rights Reserved.
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of IDGLOBAL Corp. to be materially different from the statements made herein.
For more information, please click here
Daryl Regier, CEO, President
Philip Viggiani, VP, Sales Marketing
Marc Hamilton, Chief Operating Officer
Investor Relations Toll Free: 1-866-922-4345
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Law enforcement/Anti-Counterfeiting/Security/Loss prevention
Scientists engineer tunable DNA for electronics applications June 21st, 2016
Marrying superconductors, lasers, and Bose-Einstein condensates: Chapman University Institute for Quantum Studies (IQS) member Yutaka Shikano, Ph.D., recently had research published in Scientific Reports June 20th, 2016
FEI and University of Liverpool Announce QEMSCAN Research Initiative: University of Liverpool will utilize FEI’s QEMSCAN technology to gain a better insight into oil and gas reserves & potentially change the approach to evaluating them June 22nd, 2016
French Research Team Helps Extend MRI Detection of Diseases & Lower Health-Care Costs: CEA, INSERM and G2ELab Brings Grenoble Region’s Expertise In Advanced Medicine & Magnetism Applications to H2020 IDentIFY Project June 21st, 2016